These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26322683)

  • 21. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of the bayesian prior information to evaluation of equivalence of similar biological medicinal products.
    Chiu ST; Liu JP; Chow SC
    J Biopharm Stat; 2014; 24(6):1254-63. PubMed ID: 25032488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On testing equivalence of three populations.
    Wiens BL; Iglewicz B
    J Biopharm Stat; 1999 Aug; 9(3):465-83. PubMed ID: 10473032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian approach to average bioequivalence using Bayes' factor.
    Ghosh P; Khattree R
    J Biopharm Stat; 2003 Nov; 13(4):719-34. PubMed ID: 14584718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
    Zaslavsky BG
    Biometrics; 2013 Mar; 69(1):157-63. PubMed ID: 23002906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new PK equivalence test for a bridging study.
    Novick SJ; Zhang X; Yang H
    J Biopharm Stat; 2016; 26(5):992-1002. PubMed ID: 26882145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inference of bioequivalence for log-normal distributed data with unspecified variances.
    Xu S; Hua SY; Menton R; Barker K; Menon S; D'Agostino RB
    Stat Med; 2014 Jul; 33(17):2924-38. PubMed ID: 24403216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the results obtained using the test of hypothesis, confidence intervals, and Bayesian analysis in the evaluation of bioequivalence].
    Ohki T; Ueda Y; Suzuki T
    Yakugaku Zasshi; 1985 Aug; 105(8):796-800. PubMed ID: 4087155
    [No Abstract]   [Full Text] [Related]  

  • 29. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Confidence intervals for a ratio of two independent binomial proportions.
    Price RM; Bonett DG
    Stat Med; 2008 Nov; 27(26):5497-508. PubMed ID: 18781560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian credible intervals for binomial proportions in a single patient trial.
    Oleson JJ
    Stat Methods Med Res; 2010 Dec; 19(6):559-74. PubMed ID: 20181779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A useful testing strategy in phase III trials: combined test of superiority and test of equivalence.
    Morikawa T; Yoshida M
    J Biopharm Stat; 1995 Nov; 5(3):297-306. PubMed ID: 8580930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decision-theoretic views on simultaneous testing of superiority and noninferiority.
    Koyama T; Westfall PH
    J Biopharm Stat; 2005; 15(6):943-55. PubMed ID: 16279353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The concept of therapeutic equivalence].
    Lange S; Windeler J
    Med Klin (Munich); 1997 Apr; 92(4):215-20. PubMed ID: 9221304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical vs clinical significance in product testing: can they be designed to satisfy equivalence?
    Kingman A
    J Public Health Dent; 1992; 52(6):353-60. PubMed ID: 1432923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similar, the same or just not different: a guide for deciding whether treatments are clinically equivalent. [Dept. of Medicine, Division of Cardiology, Univ. of Western Ontario, London, Ontario].
    Massel D
    Can J Cardiol; 1999 May; 15(5):556-62. PubMed ID: 10350665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An introduction to the Bayesian analysis of clinical trials.
    Lewis RJ; Wears RL
    Ann Emerg Med; 1993 Aug; 22(8):1328-36. PubMed ID: 8333640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. baymedr: an R package and web application for the calculation of Bayes factors for superiority, equivalence, and non-inferiority designs.
    Linde M; van Ravenzwaaij D
    BMC Med Res Methodol; 2023 Nov; 23(1):279. PubMed ID: 38001458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.